HPV 9-valent vaccine lot consistency trial for women
Part of Infections clinical trials.
This trial tests whether different batches of the HPV 9-valent vaccine work consistently. It's for Chinese women aged 18 to 30 who have not had any HPV vaccine or abnormal cervical screening results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a Chinese woman between 18 and 30 years old.
- You have no history of sexually transmitted diseases like syphilis or gonorrhea.
- You have never had an abnormal cervical screening or cervical dysplasia (CIN).
- You have not received any HPV vaccine before.
- You are not pregnant or breastfeeding and will use effective birth control during the study.
- You have no serious health conditions or allergies to vaccine components.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a 9-type HPV vaccine to see how well it works, how it helps the body build protection, and whether it’s safe. It’s for healthy Chinese women who have not had HPV vaccination before and meet specific health and timing requirements.
This trial tests an 11-type HPV vaccine to prevent infection from multiple HPV strains. If you enroll, you’ll receive scheduled vaccine doses and have health and gynecologic check-ins to see how well the vaccine works and is tolerated.
This study looks at the safety and immune response of a 9-valent HPV vaccine. It is for women who have already received a full course of certain HPV vaccines and are now getting a different one to see if it boosts their immunity.
This study tests a new HPV vaccine in Chinese women. It looks at whether the vaccine is safe and effective for women who have already had a different HPV vaccine (the bivalent one) and for women who have never had any HPV vaccine.
This study looks at how well the HPV vaccine works in women who have already been exposed to the virus through sexual activity. It aims to understand the immune response and potentially improve protection against HPV-related cancers.
This Phase 4 study tests whether a 9-type HPV vaccine (9vHPV) can reduce how infectious HPV is and lower the chance of HPV spreading in women who already have HPV16 and/or HPV18. It focuses on specific HPV-positive women recently diagnosed and compares what happens after vaccination.
Hear when a new Infection by Human Papilloma Virus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.